Publicaciones (209) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2

    European Journal of Obstetrics and Gynecology and Reproductive Biology: X, Vol. 21

  2. Effects of SARS-COVID-19 lockdown on menstrual patterns: A transversal large sample survey

    Medicina Clinica, Vol. 162, Núm. 12, pp. 581-587

  3. Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome

    Biology, Vol. 13, Núm. 5

  4. Update in endometriosis work-up and treatment

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 51, Núm. 1

  5. Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, Vol. 40, Núm. 1, pp. 2301554

2023

  1. Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  2. New pathogenic variant in DLX5: New clues for a clinical spectrum from split-hand-foot malformation to fibular aplasia, tibial campomelia and oligosyndactyly

    Frontiers in Genetics, Vol. 14

  3. Pathophysiology of abnormal uterine bleeding

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 50, Núm. 1

  4. m6A levels and expression of its modification genes show significant differences in breast cancer molecular subtypes

    Genes and Diseases, Vol. 10, Núm. 5, pp. 1751-1754

2022

  1. In silico identification and in vitro expression analysis of breast cancer-related m6A-SNPs

    Epigenetics, Vol. 17, Núm. 13, pp. 2144-2156

  2. Aromatase inhibitors in the treatment of endometriosis-associated pelvic pain: A systematic review

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 49, Núm. 1

  3. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group

    Maturitas, Vol. 166, pp. 65-85

  4. Evolution of oestrogen in combined hormonal contraception: From ethinylestradiol to estetrol via estradiol

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 49, Núm. 3

  5. Familial endometrial adenocarcinoma: MSH6 variant of unknown significance in the presence of phenocopy, what should be done?

    Revista Espanola de Patologia, Vol. 55, pp. S16-S20

  6. Over-the-counter access to progestin-only pills. The vision of Spanish women

    Progresos de Obstetricia y Ginecologia, Vol. 65, Núm. 6, pp. 217-228

  7. Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study

    Frontiers in Pharmacology, Vol. 13

  8. The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain

    European Journal of Contraception and Reproductive Health Care, Vol. 27, Núm. 6, pp. 494-503

  9. Urgent and unexpected findings in oncology and hematology patients: a practical approach to imaging

    Radiologia, Vol. 64, Núm. 5, pp. 464-472

2021

  1. Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies

    Annals of Medicine, Vol. 53, Núm. 1, pp. 762-769

  2. Combined hormonal contraception and COVID-19

    European Journal of Contraception and Reproductive Health Care, Vol. 26, Núm. 2, pp. 128-131